Metraipolis › archive › dc_7e3fa7a74ea6
Suppression of the myofibroblastic cancer-associated fibroblast phenotype to enhance anti-PD-1 response — Europe PMC PMID:42432797
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42432797
- DOI
- 10.1186/s13046-[numero omesso]-3
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T09:01:12.425Z
- SHA-256 of the archived text
e83fe5c912e28ab759552b55e8901857fa2131c384061ef622d3b82fda0e3ea7- Stable URL of this page
https://metraipolis.com/documento/dc_7e3fa7a74ea6
How to cite
Suppression of the myofibroblastic cancer-associated fibroblast phenotype to enhance anti-PD-1 response — Europe PMC PMID:42432797 — Europe PMC (en), https://europepmc.org/article/MED/42432797 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e3fa7a74ea6 (Metraipolis archive dc_7e3fa7a74ea6, sha256 e83fe5c912e28ab759552b55e8901857fa2131c384061ef622d3b82fda0e3ea7)
BibTeX
@misc{dc7e3fa7a74ea6,
title = {Suppression of the myofibroblastic cancer-associated fibroblast phenotype to enhance anti-PD-1 response — Europe PMC PMID:42432797},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42432797},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e3fa7a74ea6; sha256 e83fe5c912e28ab759552b55e8901857fa2131c384061ef622d3b82fda0e3ea7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42432797. Agents can read the archived copy with the MCP tool read_document.